Lupus

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

The most up to date guidelines for the treatment of systemic lupus erythematosus (SLE) were published by the European League Against Rheumatism (EULAR) in 2019.

This section covers the individual pharmacotherapeutic options for SLE, including their appropriate uses in SLE and the efficacy and safety data supporting their use.

Systemic lupus erythematosus (SLE) is an exceptionally heterogeneous disease, characterized by a wide spectrum of constitutional and organ-specific manifestations, complications and comorbidities.

Understanding the pathogenesis and pathophysiology of a disease enables the development of new treatment strategies, including targeted and personalized therapies, and increases the opportunities for screening and prevention, or, failing that, early detection and diagnosis.

Timely diagnosis of systemic lupus erythematosus (SLE) is of critical clinical importance because it allows for an early start to treatment, preventing organ damage and improving the patient’s quality of life. 

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Access free, up-to-date clinical references on the Lupus at Healio. We aid in making confident point-of-care decisions.